Join us for an engaging session that highlights One Lambda™ HybriType™ (Research Use Only) as both a powerful HLA assay and a forward-looking technology platform. This session will explore the evolution of HLA typing and the broader advancements enabled by a hybrid capture platform, including research into the value of nonclassical MHC loci, the potential to identify loss of heterozygosity, and the expanding role of high-resolution KIR genotyping. Together, these topics highlight the versatility of HybriType™ and its potential future implications for driving innovation.
